Lumiradx Ltd. -CW26LMDWFPreferred / convertible
13F holders, Q2 2024 (June 30)2holders −2
0new positions
2sold out
$0.01avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Lumiradx Ltd. -CW26 (LMDWF) in their 13F filings, down 2 from Q1 2024. 0 opened new positions and 2 sold out. The largest holders were CVS HEALTH Corp ($73K) and Ancora Advisors LLC ($9).
- Company
- Lumiradx Ltd. -CW26
- CUSIP
- G5709L117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $2K |
All 13F filers, Q1 2024 → Q2 2024: 215,701 shares sold, net −215,701 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| CVS HEALTH Corp | — | No change | 5,352,106 | $73K |
| Ancora Advisors LLC | — | No change | 15,470 | $9 |
"% of holder's portfolio" is LMDWF's weight in each manager's 13F, not the share of Lumiradx Ltd. -CW26 the manager owns.